Literature DB >> 29153464

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.

Anne W Lee1, Wai Tong Ng2, Jian Ji Pan3, Sharon S Poh4, Yong Chan Ahn5, Hussain AlHussain6, June Corry7, Cai Grau8, Vincent Grégoire9, Kevin J Harrington10, Chao Su Hu11, Dora L Kwong12, Johannes A Langendijk13, Quynh Thu Le14, Nancy Y Lee15, Jin Ching Lin16, Tai Xiang Lu17, William M Mendenhall18, Brian O'Sullivan19, Enis Ozyar20, Lester J Peters21, David I Rosenthal22, Yoke Lim Soong4, Yungan Tao23, Sue S Yom24, Joseph T Wee25.   

Abstract

PURPOSE: Target delineation in nasopharyngeal carcinoma (NPC) often proves challenging because of the notoriously narrow therapeutic margin. High doses are needed to achieve optimal levels of tumour control, and dosimetric inadequacy remains one of the most important independent factors affecting treatment outcome.
METHOD: A review of the available literature addressing the natural behaviour of NPC and correlation between clinical and pathological aspects of the disease was conducted. Existing international guidelines as well as published protocols specified by clinical trials on contouring of clinical target volumes (CTV) were compared. This information was then summarized into a preliminary draft guideline which was then circulated to international experts in the field for exchange of opinions and subsequent voting on areas with the greatest controversies.
RESULTS: Common areas of uncertainty and variation in practices among experts experienced in radiation therapy for NPC were elucidated. Iterative revisions were made based on extensive discussion and final voting on controversial areas by the expert panel, to formulate the recommendations on contouring of CTV based on optimal geometric expansion and anatomical editing for those structures with substantial risk of microscopic infiltration.
CONCLUSION: Through this comprehensive review of available evidence and best practices at major institutions, as well as interactive exchange of vast experience by international experts, this set of consensus guidelines has been developed to provide a practical reference for appropriate contouring to ensure optimal target coverage. However, the final decision on the treatment volumes should be based on full consideration of individual patients' factors and facilities of an individual centre (including the quality of imaging methods and the precision of treatment delivery).
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical target volume (CTV); Delineation; Gross target volume (GTV); Guideline; Nasopharyngeal carcinoma

Mesh:

Year:  2017        PMID: 29153464     DOI: 10.1016/j.radonc.2017.10.032

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  42 in total

Review 1.  Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma.

Authors:  Elaine Johanna Limkin; Pierre Blanchard
Journal:  Br J Radiol       Date:  2019-05-31       Impact factor: 3.039

Review 2.  Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician.

Authors:  Jolien Heukelom; Clifton David Fuller
Journal:  Semin Radiat Oncol       Date:  2019-07       Impact factor: 5.934

3.  Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.

Authors:  Yongfeng Piao; Caineng Cao; Yuanfan Xu; Shuang Huang; Feng Jiang; Ting Jin; Qifeng Jin; Yonghong Hua; Qiaoying Hu; Xiaozhong Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-29       Impact factor: 2.503

4.  The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning.

Authors:  Kevin Chiu; Peter Hoskin; Amit Gupta; Roeum Butt; Samsara Terparia; Louise Codd; Yatman Tsang; Jyotsna Bhudia; Helen Killen; Clare Kane; Subhadip Ghoshray; Catherine Lemon; Daniel Megias
Journal:  Br J Radiol       Date:  2021-12-21       Impact factor: 3.039

5.  Synthetic MRI in differentiating benign from metastatic retropharyngeal lymph node: combination with diffusion-weighted imaging.

Authors:  Peng Wang; Shudong Hu; Xiuyu Wang; Yuxi Ge; Jing Zhao; Hongyan Qiao; Jun Chang; Weiqiang Dou; Heng Zhang
Journal:  Eur Radiol       Date:  2022-08-11       Impact factor: 7.034

6.  [Is elective irradiation of lymph node levels IV and Vb necessary in nasopharyngeal carcinoma?]

Authors:  Sabine Semrau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2022-08-11       Impact factor: 4.033

7.  Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases.

Authors:  Jenny Bertholet; Paul-Henry Mackeprang; Silvan Mueller; Gian Guyer; Hannes A Loebner; Yanick Wyss; Daniel Frei; Werner Volken; Olgun Elicin; Daniel M Aebersold; Michael K Fix; Peter Manser
Journal:  Radiat Oncol       Date:  2022-07-15       Impact factor: 4.309

Review 8.  Nasopharyngeal carcinoma: an evolving paradigm.

Authors:  Kenneth C W Wong; Edwin P Hui; Kwok-Wai Lo; Wai Kei Jacky Lam; David Johnson; Lili Li; Qian Tao; Kwan Chee Allen Chan; Ka-Fai To; Ann D King; Brigette B Y Ma; Anthony T C Chan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-30       Impact factor: 66.675

9.  Association of tumor downstaging after neoadjuvant chemotherapy with survival in patients with locally advanced nasopharyngeal carcinoma: a retrospective cohort study.

Authors:  Weifeng Wang; Shaohua Peng; Huanliang Wu; Yunxiu Luo; Feng Yuan; Zhiren Lin; Gang Cheng; Shengmin Chen
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-23       Impact factor: 4.553

10.  Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives.

Authors:  Sharon Shuxian Poh; Yoke Lim Soong; Kiattisa Sommat; Chwee Ming Lim; Kam Weng Fong; Terence Wk Tan; Melvin Lk Chua; Fu Qiang Wang; Jing Hu; Joseph Ts Wee
Journal:  Cancer Commun (Lond)       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.